// App-Quantinova.ai

: The Difference Between Cystatin C- and Creatinine-Based Kidney Function Assessment is Associated With Clinical Outcomes, Quality of Life and Frailty in Patients With Heart Failure and Reduced Ejection Fraction Insights From PARADIGM-HF

Researchers

Presenter

  • Alberto Pinsino

Principal Investigators

  • Matthew R Carey

  • Husain A Syed

  • Douglas L Jennings

  • Sumit Mohan

  • Koji Takeda

  • Yoshifumi Naka

  • Gabriel T Sayer

  • Nir Uriel

  • Ryan T Demmer

  • Paolo C Colombo

  • Melana Yuzefpolskaya

Medical Centers

  • Univ of Minnesota, MN

  • Columbia Univ Med Ctr, New York, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Heart failure with reduced ejection fraction

Biomarkers

  • Cystatin C

Drug/Treatment

  • Angiotensin II

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved